{"id":"W4361988864","doi":"10.1177/17588359231156382","title":"A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Medical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"FP7 Health; Pharmacyclics; Sanofi Genzyme; Genentech; Daiichi Sankyo Europe; National Cancer Institute; Servier; AstraZeneca; Institut National Du Cancer; Canadian Cancer Society; Foundation Medicine; Fondation ARC pour la Recherche sur le Cancer; Seagen; Puma Biotechnology; Actuate Therapeutics; Symphogen; Pfizer; Incyte; Grifols; EQRx; BeiGene; European Commission; Sanofi; Halozyme; Chugai Pharmaceutical; Israel Science Foundation; Ipsen; Array BioPharma; Bristol-Myers Squibb; Eli Lilly and Company; American Society of Clinical Oncology; Instituto de Salud Carlos III; Amgen; Novartis Pharmaceuticals Corporation; Les Laboratories Pierre Fabre","keywords":"Medicine; Oncology; Clinical trial; Internal medicine; Immunotherapy; Metastasis; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01600995,0.0002900724,0.002068461,0.0005411098,0.0000627172,0.00001186205,0.0002917112,0.0007814393,0.0002692219],"category_scores_gemma":[0.001152673,0.0002235188,0.0002620879,0.00113585,0.0008023204,0.0001116606,0.00006678901,0.00102895,0.0000261249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004044546,"about_ca_system_score_gemma":0.0009373907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003476799,"about_ca_topic_score_gemma":0.0002078101,"domain_scores_codex":[0.9934338,0.002677278,0.002093633,0.0006702619,0.0004491016,0.0006759679],"domain_scores_gemma":[0.9938875,0.005072866,0.0002377393,0.0003326684,0.00004496236,0.0004242814],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0103993,0.001292511,0.002787723,0.00007028287,0.0001783879,0.0001819283,0.001821674,0.00008451656,0.0007656322,0.00116808,0.000190435,0.9810596],"study_design_scores_gemma":[0.03882923,0.006083194,0.03002806,0.0003116846,0.0002599714,0.0005162099,0.004421364,0.008778416,0.00006590941,0.005375455,0.904776,0.0005545192],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.67342,0.1153553,0.05079271,0.1162963,0.006457215,0.009559622,0.0000492289,0.0006750655,0.02739456],"genre_scores_gemma":[0.7610797,0.1881047,0.01034595,0.03788986,0.0007554988,0.001108347,0.00005569245,0.000093842,0.0005663504],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.980505,"threshold_uncertainty_score":0.911483,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1778064220423873,"score_gpt":0.5108081939300281,"score_spread":0.3330017718876408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}